Month: May 2016

Background FAQ on Glivec (imatinib) compulsory license in Colombia

Posted on by Andrew Goldman

Warning: call_user_func_array() expects parameter 1 to be a valid callback, function 'wp_embed_excerpt_more' not found or invalid function name in /home/keionli38/public_html/wp-includes/class-wp-hook.php on line 341

(More on Colombia here: /colombia) For more information, contact: (U.S.) Andrew Goldman, KEI: andrew.goldman@keionline.org or +1 (202) 332-2670 (Colombia) Andrea Carolina Reyes Rojas, Misión Salud: subdireccion@mision-salud.org (Colombia) Dr. Francisco Rossi, IFARMA: francisco_rossi@hotmail.com Frequently Asked Questions What is happening in Colombia…

Letter from KEI, Public Citizen, Oxfam America and Health GAP to Senator Hatch, regarding Colombia Compulsory License

Posted on by James Love

Attached is a letter that KEI, Public Citizen, Oxfam America and Health GAP have sent to Senator Hatch, via the Senate Finance Committee, objecting to the pressure his office has put on Colombia over a compulsory license on patents held by Novartis for the cancer drug Gleevec. This refers to the accounts of pressure from Hatch’s office that are described in two letters from the Colombia Embassy in Washington, dated April 27 and April 28, which were recently leaked. Continue Reading →

13 non-profits urge Senate HELP Committee to block floor amendments to 21st Century Cures Act counterpart

Posted on by Zack Struver

Before the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) presents a legislative package of healthcare reforms to the Senate floor for an up-or-down vote, 13 consumer, patient and health non-profit groups sent a letter to HELP Chairman and Ranking Member to ensure that the final legislative package includes only those bills that the HELP Committee reviewed in mark-up sessions.

Continue Reading →

Uncategorized

122 experts defend Colombia’s right to issue compulsory license on imatinib in face of U.S. pressure

Posted on by Zack Struver

(More on Colombia here: /colombia)

On May 16, 2016, 122 health, trade, and intellectual property experts defended the Colombian government’s right to issue a compulsory license on imatinib, an expensive leukemia drug that is being sold at a high price by the Swiss drug company Novartis, in a letter to Colombian President Juan Manuel Santos.

Continue Reading →

Uncategorized

2016: MeiraGTx, NIH license of patents on AAV­Mediated Aquaporin Gene Transfer To Treat Sjögren’s Syndrome

Posted on by James Love

Warning: call_user_func_array() expects parameter 1 to be a valid callback, function 'wp_embed_excerpt_more' not found or invalid function name in /home/keionli38/public_html/wp-includes/class-wp-hook.php on line 341

(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) May 16th, 2016 Sally Hu, Ph.D., M.B.A., Senior Licensing and Patenting Manager, Office of Technology Transfer and Innovation Access, National Institute of Dental and Craniofacial…

SCCR32: Conclusion by the chair and comments from the floor

Posted on by KEI Staff

Warning: call_user_func_array() expects parameter 1 to be a valid callback, function 'wp_embed_excerpt_more' not found or invalid function name in /home/keionli38/public_html/wp-includes/class-wp-hook.php on line 341

SCCR 32 Conclusions proposed by the chair. Late Friday May 13, 2016. Nigeria, Bahamas, Brazil, South Africa and Egypt were exceptionnaly interesting. Here is most of what was said including the reading of the proposed conclusions and the comments from…

SCCR 32 KEI on Cross Border Uses

Posted on by KEI Staff

Warning: call_user_func_array() expects parameter 1 to be a valid callback, function 'wp_embed_excerpt_more' not found or invalid function name in /home/keionli38/public_html/wp-includes/class-wp-hook.php on line 341

KEI: I wanted to just address some of the issues on the cross-border relationship with the exceptions. I know the publisher mentioned mention to three step test. There are three important exceptions that are not related to the three step…

SCCR 32 Day 4 Some countries statements re Libraries & Archives

Posted on by KEI Staff

Warning: call_user_func_array() expects parameter 1 to be a valid callback, function 'wp_embed_excerpt_more' not found or invalid function name in /home/keionli38/public_html/wp-includes/class-wp-hook.php on line 341

> SOUTH AFRICA: Thank you, Mr. Chairman. At the outset, South Africa supports the statement made by Nigeria on behalf of the Africa Group. 2015 was a milestone in the global calendar. We adopted agenda 2030, which outlined 17 goals…

SCCR 32 DAY 4 Groups on Libraries and Archives Issues

Posted on by KEI Staff

Warning: call_user_func_array() expects parameter 1 to be a valid callback, function 'wp_embed_excerpt_more' not found or invalid function name in /home/keionli38/public_html/wp-includes/class-wp-hook.php on line 341

Day 4. May 12, 2016 After the Chair Summary of the previous discussions on libraries and archives limitations and exceptions we heard the goup statements. In brief, Group B (the rich countries) stated that the discussions should continue to get…

SCCR 32: EIFL.NET on Orphan works

Posted on by KEI Staff

Warning: call_user_func_array() expects parameter 1 to be a valid callback, function 'wp_embed_excerpt_more' not found or invalid function name in /home/keionli38/public_html/wp-includes/class-wp-hook.php on line 341

>> EIFL.NET: I will start with retracted and withdrawn works. So libraries and archives have a mandate to pre seven public record for the future. In the analog aenvironment exhaustion to the distribution right provides legal means to insure its…

Uncategorized